Covid-19: Doctors lobbying for Ivermectin must approach Sahpra to run clinical trials – Zweli Mkhize
Health Minister Zweli Mkhize says doctors who want to use Ivermectin to treat Covid-19 symptoms should register with the South African Health Products Regulatory Authority (Sahpra) to run clinical trials on the drug.
Mkhize was speaking during a visit to various KwaZulu-Natal hospitals on Monday.
The minister has been inundated with messages from people lobbying for the drug and has seen letters that were written to the president for the same reason.
"That regulatory authority has indicated that everyone is welcome to order the drugs and participate in a trial and therefore the authorisation can be given on that basis. That also means that not the regulator, but the doctors who are conducting that trial will have to be the ones who take responsibility," Mkhize said on Monday.
"I would suggest that they take that route until we can get enough research reports to allow the drug to be registered across different jurisdictions. So, as we speak right now, we are saying doctors who wish to use it have to follow those rules. If it is done in a research format that has been prescribed by Sahpra, they should be able to take responsibility for it," he added.
The drug has been making headlines in South Africa. There have been several reports of doctors who not only support it but prescribe it to patients.
The drug is usually used for the treatment of parasites in animals and several tropical diseases in humans that are not commonly seen in South Africa.
Research in some countries suggested that the drug could be used to manage Covid-19 symptoms.
In South Africa, it is registered under the Department of Agriculture for use in animals. As such, it is illegal for people who do not have permits or are not trained to use it, to have it in their possession.
"The reports that have come about are not yet reflected in the kind of trials we would have needed for Ivermectin to be registered. So what we do need is an understanding that from where we see it, we will only register a drug that is based on the decision of Sahpra," Mkhize said.
At the beginning of January, a 43-year-old man was arrested at King Shaka International Airport in Durban in alleged possession of Ivermectin parasiticide tablets valued at R100 000. He was returning from Dubai when the 2 464 tablets were allegedly found in his hand luggage.
Meanwhile, provincial health MEC Nomagugu Simelane-Zulu said they would probe media reports of patients who died in certain hospitals as a result of load-shedding. She said protocol dictated that generators should kick in less than 20 seconds after the hospital loses power.
Simelane-Zulu said that in places like uMgungundlovu, power outages were rife but they had not lost any patients as a result of the outages.
Mkhize added that there was a need to be cautious about making statements on the allegations without tangible evidence.
Mkhize will also conduct similar visits in Limpopo and Gauteng.
Article Enquiry
Email Article
Save Article
Feedback
To advertise email advertising@creamermedia.co.za or click here
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation

















